Researchers have discovered that drugs, such as heart burn medications, which reduce gastric acidity, are potential risk factors for Clostridium difficile infection outside of hospitals. The new research to be published in the Journal of the American Medical Association (JAMA) tomorrow focuses on community-acquired C. difficile, and is a follow-up to previous work by the same group that demonstrated an increased risk from these medications in hospital settings.
"We believe drugs that reduce gastric acidity provide a more hospitable environment within which C. difficile bacteria can colonize," says MUHC researcher and lead author of the new study Dr. Sandra Dial. Numerous studies worldwide have documented increases in hospital C. difficile associated disease, but this study is the first to suggest this trend is mirrored in the general community. Dr. Sandra Dial is Attending Staff in the Department of Critical Care at both the MUHC and Jewish General Hospital (JGH) and an Assistant Professor of Medicine at McGill University.
Using data from the United Kingdom General Practice Research Database (GPRD), researchers traced variation in community C. difficile associated disease over a 10-year period. "In 1994 there was less than one C. difficile case per 100,000 people in the database," says Dr. Dial. "By 2004, this number had increased exponentially to 22 cases to per 100,000." It is important to note however, that community rates are still much lower than hospitals overall.
Ian Popple | EurekAlert!
PET imaging tracks Zika virus infection, disease progression in mouse model
20.09.2017 | US Army Medical Research Institute of Infectious Diseases
'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton
19.09.2017 | Event News
12.09.2017 | Event News
06.09.2017 | Event News
20.09.2017 | Life Sciences
20.09.2017 | Power and Electrical Engineering
20.09.2017 | Physics and Astronomy